title: [Prostate cancer and metabolic syndrome].
abstract: The prevalence of metabolic syndrome (MS) is increasing in Japan because of westernization of diet and lifestyle. Previous epidemiological studies have demonstrated MS to relate with the malignant potential of prostate cancer (PCa) while its relationship to the risk of PCa has been still controversial. Several pathologies involved in MS, such as insulin resistance, abnormality of secreted adipokines, chronic inflammation, alteration of sex hormones, have been reported to affect the progression of PCa. Based on these evidences, clinical studies for PCa patients have been tried for suppressing the progression of PCa through the management of MS.
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Nagamatsu
authors.forename: Jun
authors.initials: J
authors.lastname: Teishima
authors.forename: Shogo
authors.initials: S
authors.lastname: Inoue
authors.forename: Tetsutaro
authors.initials: T
authors.lastname: Hayashi
authors.forename: Akio
authors.initials: A
authors.lastname: Matsubara
mesh_terms: D018450:Disease Progression; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications* / Q000628:therapy; D009765:Obesity / Q000150:complications; D015995:Prevalence; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology